These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39188553)

  • 21. Novel modeling approach integrating population pharmacokinetics and interspecies scaling to predict human pharmacokinetics of the new anti-tuberculosis agent telacebec (Q203).
    Kim J; Kim TH; Choi J; Nam K; Shin BS; Shin S
    Biomed Pharmacother; 2023 Nov; 167():115441. PubMed ID: 37696082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of preclinical data to support the design of the first in man study of LY2181308, a second generation antisense oligonucleotide.
    Callies S; André V; Patel B; Waters D; Francis P; Burgess M; Lahn M
    Br J Clin Pharmacol; 2011 Mar; 71(3):416-28. PubMed ID: 21284701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models.
    Zhang L; Feng F; Wang X; Liang H; Yao X; Liu D
    Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics/toxicodynamics (PK/TD) relationship of SAM486A in phase I studies in patients with advanced cancers.
    Zhou H; Choi L; Lau H; Bruntsch U; Vries EE; Eckhardt G; Oosterom AT; Verweij J; Schran H; Barbet N; Linnartz R; Capdeville R
    J Clin Pharmacol; 2000 Mar; 40(3):275-83. PubMed ID: 10709156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population Pharmacokinetics and Pharmacodynamics Modelling of Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome.
    Yang S; Dumitrescu TP
    Drugs R D; 2017 Mar; 17(1):145-158. PubMed ID: 28004376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allometric pharmacokinetic scaling: towards the prediction of human oral pharmacokinetics.
    Feng MR; Lou X; Brown RR; Hutchaleelaha A
    Pharm Res; 2000 Apr; 17(4):410-8. PubMed ID: 10870984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
    Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
    J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linear pharmacokinetic parameters for monoclonal antibodies are similar within a species and across different pharmacological targets: A comparison between human, cynomolgus monkey and hFcRn Tg32 transgenic mouse using a population-modeling approach.
    Betts A; Keunecke A; van Steeg TJ; van der Graaf PH; Avery LB; Jones H; Berkhout J
    MAbs; 2018 Jul; 10(5):751-764. PubMed ID: 29634430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Population Pharmacokinetics of Meropenem in Adult Patients With Rifampicin-Sensitive Pulmonary Tuberculosis.
    Abulfathi AA; de Jager V; van Brakel E; Reuter H; Gupte N; Vanker N; Barnes GL; Nuermberger E; Dorman SE; Diacon AH; Dooley KE; Svensson EM
    Front Pharmacol; 2021; 12():637618. PubMed ID: 34267655
    [No Abstract]   [Full Text] [Related]  

  • 30. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covariates of intravenous paracetamol pharmacokinetics in adults.
    Allegaert K; Olkkola KT; Owens KH; Van de Velde M; de Maat MM; Anderson BJ;
    BMC Anesthesiol; 2014; 14():77. PubMed ID: 25342929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with in Vitro-in Vivo Extrapolation and Allometric Scaling.
    Naritomi Y; Sanoh S; Ohta S
    Biol Pharm Bull; 2019; 42(3):327-336. PubMed ID: 30828063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interspecies Scaling of Antibody-Drug Conjugates (ADC) for the Prediction of Human Clearance.
    Mahmood I
    Antibodies (Basel); 2021 Jan; 10(1):. PubMed ID: 33430196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods.
    Liu D; Ma X; Liu Y; Zhou H; Shi C; Wu F; Jiang J; Hu P
    Eur J Pharm Sci; 2016 Jun; 89():73-82. PubMed ID: 27108678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The application of allometric scaling principles to predict pharmacokinetic parameters across species.
    Huang Q; Riviere JE
    Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1241-53. PubMed ID: 24984569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calculation of a First-In-Man Dose of 7-
    Noh K; Kang ΨW
    Biomol Ther (Seoul); 2017 Nov; 25(6):648-658. PubMed ID: 28274094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates.
    Gallo Cantafio ME; Nielsen BS; Mignogna C; Arbitrio M; Botta C; Frandsen NM; Rolfo C; Tagliaferri P; Tassone P; Di Martino MT
    Mol Ther Nucleic Acids; 2016 Jun; 5(6):. PubMed ID: 27327137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of Clearance and Dose of Midazolam in Preterm and Term Neonates: A Comparative Study Between Allometric Scaling and Physiologically Based Pharmacokinetic Modeling.
    Mansoor N; Ahmad T; Alam Khan R; Sharib SM; Mahmood I
    Am J Ther; 2019; 26(1):e32-e37. PubMed ID: 27574923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Prediction of Human Pharmacokinetics and Pharmacodynamics of CKD519, a Potent Inhibitor of Cholesteryl Ester Transfer Protein (CETP).
    Choi S; Han S; Jeon S; Yim DS
    Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31311144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method.
    Song L; Xue J; Zhang J; Li S; Liu D; Zhou T
    Eur J Pharm Sci; 2021 Mar; 158():105584. PubMed ID: 33039565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.